Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Antibodies against interferon-beta in neuromyelitis optica patients.
BAb and MxA as functional biomarkers in routine clinical laboratories for the determination of anti-IFN-beta antibodies and their bioactivity levels in Multiple Sclerosis patients.
An MRI review of acquired corpus callosum lesions.
Safety of TNF inhibitors in adolescents and children.
Systematic framework to evaluate the status of physical activity research for persons with multiple sclerosis.
MxA mRNA Quantification and Disability Progression in Interferon Beta-Treated Multiple Sclerosis Patients.
Myelin Oligodendrocyte Glycoprotein (MOG35-55) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice.
Juvenile myoclonic epilepsy with multiple sclerosis: Is there a dual role for valproate?
Natalizumab and fingolimod: Insight into their relative efficacies in clinical practice.
Teaching NeuroImages: Neuromyelitis optica misdiagnosed as spinal cord tumor.
Adaptive voxel, texture and temporal conditional random fields for detection of Gad-enhancing multiple sclerosis lesions in brain MRI.
Erratum to: Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study.
Multicystic demyelinating myelopathy: Widening spectrum of pediatric aquaporin-4 autoimmunity.
A peptide nucleic acid (PNA)-mediated polymerase chain reaction clamping allows the selective inhibition of the ERVWE1 gene amplification.
Risk of suicide and suicide attempts associated with physical disorders: a population-based, balancing score-matched analysis.
Sound Lateralization Test Distinguishes Unimpaired MS Patients from Healthy Controls.
Human recombinant domain antibodies against multiple sclerosis antigenic peptide CSF114(Glc).
Clinical Usefulness of Cell-based Indirect Immunofluorescence Assay for the Detection of Aquaporin-4 Antibodies in Neuromyelitis Optica Spectrum Disorder.
Heterogeneity of cortical lesions in multiple sclerosis: Clinical and pathologic implications.
Long-term results from a phase 2 extension study of fingolimod at high and approved dose in relapsing multiple sclerosis.
Innovative quantitative testing of hand function in Charcot-Marie-Tooth neuropathy.
Association Between Urinary Symptoms and Urinary Tract Infection in Patients With Multiple Sclerosis.
A new mechanism of nervous system plasticity: activity-dependent myelination.
Biointegrator announced that it has successfully launched Neskler® - a first generic of Gilenya® in Russia and EuroAsian Economic Union
An early British case of neuromyelitis optica (1850).

Pages